Proteomics

Dataset Information

0

Proteomic analysis of Brugia malayi microfilaria-derived extracellular vesicles


ABSTRACT: We have previously shown that the microfilarial (mf) stage of Brugia malayi can inhibit the mammalian target of rapamycin (mTOR; a conserved serine/threonine kinase critical for immune regulation and cellular growth) in human dendritic cells (DC) and we have proposed that this mTOR inhibition is associated with the DC dysfunction seen in filarial infections. Extracellular vesicles (EVs) contain many proteins and nucleic acids including microRNAs (miRNAs) that might affect a variety of intracellular pathways. Thus, EVs secreted from mf may elucidate the mechanism by which the parasite is able to modulate the host immune response during infection. EVs, purified from mf of Brugia malayi and confirmed by size through nanoparticle tracking analysis, were assessed by miRNA microarrays and shown to be enriched (>2fold, p-value<0.05, FDR=0.05) for miR100, miR71, miR34, and miR7. The microarray analysis compared mf-derived EVs and mf supernatant. After confirming their presence in EVs using qPCR for these miRNA targets, web-based target predictions (using MIRPathv3, TarBAse and MicroT-CD) predicted that miR100 targeted mTOR and its downstream regulatory protein 4E-BP1 respectively. Our previous data with live parasites demonstrated that mf downregulate the phosphorylation of mTOR and its downstream effectors. Additionally, our proteomic analysis of the mf-derived EVs revealed the presence of proteins commonly found in these vesicles. We confirmed internalization of mf-derived EVs by human DCs and monocytes using confocal microscopy and flow cytometry, and further demonstrated through flow cytometry, that mf-derived EVs downregulate the phosphorylation of mTOR in human monocytes (THP-1 cells) to the same degree that rapamycin (a known mTOR inhibitor) does. Our data collectively suggest that mf release EVs that interact with host cells, such as DC, to modulate host responses.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Brugia Malayi

TISSUE(S): Extracellular Vesicle

DISEASE(S): Disease Free

SUBMITTER: Alessandra Ricciardi  

LAB HEAD: Dr. Thomas Nutman

PROVIDER: PXD021844 | Pride | 2021-01-12

REPOSITORIES: Pride

altmetric image

Publications

Extracellular vesicles released from the filarial parasite Brugia malayi downregulate the host mTOR pathway.

Ricciardi Alessandra A   Bennuru Sasisekhar S   Tariq Sameha S   Kaur Sukhbir S   Wu Weiwei W   Elkahloun Abdel G AG   Arakelyan Anush A   Shaik Jahangheer J   Dorward David W DW   Nutman Thomas B TB   Tolouei Semnani Roshanak R  

PLoS neglected tropical diseases 20210107 1


We have previously shown that the microfilarial (mf) stage of Brugia malayi can inhibit the mammalian target of rapamycin (mTOR; a conserved serine/threonine kinase critical for immune regulation and cellular growth) in human dendritic cells (DC) and we have proposed that this mTOR inhibition is associated with the DC dysfunction seen in filarial infections. Extracellular vesicles (EVs) contain many proteins and nucleic acids including microRNAs (miRNAs) that might affect a variety of intracellu  ...[more]

Similar Datasets

2021-01-12 | GSE157226 | GEO
2009-10-01 | E-GEOD-15017 | biostudies-arrayexpress
2013-06-19 | E-GEOD-47897 | biostudies-arrayexpress
2015-05-07 | E-GEOD-59958 | biostudies-arrayexpress
2020-12-31 | E-MTAB-9618 | biostudies-arrayexpress
2015-02-21 | E-GEOD-66165 | biostudies-arrayexpress
2022-11-16 | E-MTAB-11910 | biostudies-arrayexpress
2020-08-20 | E-MTAB-8254 | biostudies-arrayexpress
2010-05-22 | E-GEOD-14939 | biostudies-arrayexpress
2008-10-25 | E-GEOD-12770 | biostudies-arrayexpress